By Brendan Pierson (Reuters) – Swiss drugmaker Novartis AG has agreed to pay $30 million to settle claims by health plans and consumers that it … Read more
ZURICH (Reuters) – Novartis on Monday announced the appointment of Gilbert Ghostine as chairman-designate of Sandoz, the generics unit Novartis wants to spin off later … Read more
(Reuters) -Swiss drugmaker Novartis AG is considering to sell its ophthalmology and respiratory units, a Bloomberg report said on Wednesday citing people familiar with the … Read more
DUBLIN (Reuters) – Novartis said on Thursday that it would cut up to 400 jobs in Ireland, or about a quarter of its workforce there, … Read more
ZURICH (Reuters) – Pharmaceuticals company Novartis plans to close a Sandoz generics plant in Wilson, North Carolina, around the end of 2023, it said on … Read more
NEW YORK, July 13, 2022 — Pomerantz LLP is investigating claims on behalf of investors of Novartis AG (“Novartis” or the “Company”) (NYSE: NVS). Such investors are advised … Read more
NEW YORK, July 5, 2022 — Pomerantz LLP is investigating claims on behalf of investors of Novartis AG (“Novartis” or the “Company”) (NYSE: NVS). Such investors are advised … Read more
FRANKFURT – A targeted oral drug combination by Novartis won U.S. approval for use in a wide range of advanced solid tumours that are driven … Read more
FRANKFURT – An oral drug combination by Swiss pharmaceuticals company Novartis showed promise in treating a subgroup of patients suffering from a common childhood brain … Read more
ZURICH – Swiss drugmaker Novartis will cut thousands of jobs worldwide as it combines its pharma and oncology businesses in a reorganisation announced last week, … Read more
GENEVA – Swiss drugmaker Novartis said on Tuesday it was suspending capital investments, media advertising, and other promotional activities in Russia but remained committed to … Read more
– Private equity firms Blackstone Inc and Carlyle Group Inc are in talks about potentially teaming up on a bid for Swiss drugmaker Novartis’ generics … Read more